Target intelligence / Profile preview

ribosomal protein L32 pseudogene 22 (RPL32P22)

Target
RPL32P22
Molecular classification
Other (processed pseudogene)
01

Overview

RPL32P22 is a processed pseudogene related to the ribosomal protein L32 (RPL32) gene family. Unlike the functional RPL32 gene, which encodes a protein component of the large (60S) ribosomal subunit involved in protein synthesis[1][4], RPL32P22 does not produce a functional protein and has no known physiological role[3]. There are multiple RPL32-related pseudogenes across the genome, but none of these—including RPL32P22—are considered drug targets or used for therapeutic interventions[1][3][4]. Some pseudogenes from the RPL32 family (e.g., RPL32P3) can have regulatory functions in specific contexts, but there is no evidence that RPL32P22 itself plays such a role[7]. RPL32P22 is not implicated in any disease or clinical context, and there are no drugs, mechanisms of action, or biomarkers associated with it[2][3][4].

Other names
RPL32_14_1010RPL32P22
02

Biological functions

Other (no known direct biological function; does not encode a protein)
03

Disease associations

Other (no reported direct role in disease; parental RPL32 gene associated with rare disorders[4])

Beyond the preview

Go deeper on ribosomal protein L32 pseudogene 22 (RPL32P22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L32 pseudogene 22 (RPL32P22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call